25 XP   0   0   10

Sino Biopharmaceutical Ltd ADR
Buy, Hold or Sell?

Let's analyse Sino Biopharmaceutical Ltd ADR together

PenkeI guess you are interested in Sino Biopharmaceutical Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sino Biopharmaceutical Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sino Biopharmaceutical Ltd ADR

I send you an email if I find something interesting about Sino Biopharmaceutical Ltd ADR.

Quick analysis of Sino Biopharmaceutical Ltd ADR (30 sec.)










What can you expect buying and holding a share of Sino Biopharmaceutical Ltd ADR? (30 sec.)

How much money do you get?

How much money do you get?
$0.74
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$5.52
Expected worth in 1 year
$5.95
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$1.17
Return On Investment
14.2%

For what price can you sell your share?

Current Price per Share
$8.20
Expected price per share
$7.96 - $8.95
How sure are you?
50%

1. Valuation of Sino Biopharmaceutical Ltd ADR (5 min.)




Live pricePrice per Share (EOD)

$8.20

Intrinsic Value Per Share

$4.45 - $7.71

Total Value Per Share

$9.97 - $13.23

2. Growth of Sino Biopharmaceutical Ltd ADR (5 min.)




Is Sino Biopharmaceutical Ltd ADR growing?

Current yearPrevious yearGrowGrow %
How rich?$5.2b$5.2b$29.6m0.6%

How much money is Sino Biopharmaceutical Ltd ADR making?

Current yearPrevious yearGrowGrow %
Making money$352m$2b-$1.6b-474.3%
Net Profit Margin8.8%54.4%--

How much money comes from the company's main activities?

3. Financial Health of Sino Biopharmaceutical Ltd ADR (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#20 / 1031

Most Revenue
#4 / 1031

Most Profit
#11 / 1031

Most Efficient
#129 / 1031

What can you expect buying and holding a share of Sino Biopharmaceutical Ltd ADR? (5 min.)

Welcome investor! Sino Biopharmaceutical Ltd ADR's management wants to use your money to grow the business. In return you get a share of Sino Biopharmaceutical Ltd ADR.

What can you expect buying and holding a share of Sino Biopharmaceutical Ltd ADR?

First you should know what it really means to hold a share of Sino Biopharmaceutical Ltd ADR. And how you can make/lose money.

Speculation

The Price per Share of Sino Biopharmaceutical Ltd ADR is $8.2. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sino Biopharmaceutical Ltd ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sino Biopharmaceutical Ltd ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.52. Based on the TTM, the Book Value Change Per Share is $0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $2.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.18 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sino Biopharmaceutical Ltd ADR.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.374.5%0.374.5%2.1025.6%0.9211.3%0.587.1%
Usd Book Value Change Per Share0.111.3%0.111.3%2.1225.8%0.738.9%0.485.9%
Usd Dividend Per Share0.182.3%0.182.3%0.131.6%0.141.8%0.091.2%
Usd Total Gains Per Share0.293.6%0.293.6%2.2527.4%0.8810.7%0.587.1%
Usd Price Per Share11.71-11.71-14.01-21.53-16.09-
Price to Earnings Ratio31.63-31.63-6.68-41.20-37.24-
Price-to-Total Gains Ratio40.19-40.19-6.23-25.04-46.26-
Price to Book Ratio2.12-2.12-2.59-4.28-5.01-
Price-to-Total Gains Ratio40.19-40.19-6.23-25.04-46.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.2
Number of shares121
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.180.14
Usd Book Value Change Per Share0.110.73
Usd Total Gains Per Share0.290.88
Gains per Quarter (121 shares)35.26106.12
Gains per Year (121 shares)141.04424.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1895213170355414
2179103272139710838
326815541320910651262
435720755427814201686
544725969534817742110
653631083641821292534
762536297748724842958
8714414111855728393382
9804466125962731943806
10893517140069635494230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%22.02.00.091.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%23.01.00.095.8%

Fundamentals of Sino Biopharmaceutical Ltd ADR

About Sino Biopharmaceutical Ltd ADR

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Fundamental data was last updated by Penke on 2024-03-12 21:01:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Sino Biopharmaceutical Ltd ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sino Biopharmaceutical Ltd ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Sino Biopharmaceutical Ltd ADR to the Biotechnology industry mean.
  • A Net Profit Margin of 8.8% means that $0.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sino Biopharmaceutical Ltd ADR:

  • The MRQ is 8.8%. The company is making a profit. +1
  • The TTM is 8.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.8%TTM8.8%0.0%
TTM8.8%YOY54.4%-45.5%
TTM8.8%5Y25.9%-17.0%
5Y25.9%10Y19.1%+6.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.8%-171.8%+180.6%
TTM8.8%-205.8%+214.6%
YOY54.4%-262.1%+316.5%
5Y25.9%-455.6%+481.5%
10Y19.1%-589.0%+608.1%
1.1.2. Return on Assets

Shows how efficient Sino Biopharmaceutical Ltd ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sino Biopharmaceutical Ltd ADR to the Biotechnology industry mean.
  • 4.0% Return on Assets means that Sino Biopharmaceutical Ltd ADR generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sino Biopharmaceutical Ltd ADR:

  • The MRQ is 4.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.0%TTM4.0%0.0%
TTM4.0%YOY24.1%-20.2%
TTM4.0%5Y11.4%-7.4%
5Y11.4%10Y10.8%+0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0%-12.5%+16.5%
TTM4.0%-12.2%+16.2%
YOY24.1%-11.2%+35.3%
5Y11.4%-13.4%+24.8%
10Y10.8%-14.7%+25.5%
1.1.3. Return on Equity

Shows how efficient Sino Biopharmaceutical Ltd ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sino Biopharmaceutical Ltd ADR to the Biotechnology industry mean.
  • 8.6% Return on Equity means Sino Biopharmaceutical Ltd ADR generated $0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sino Biopharmaceutical Ltd ADR:

  • The MRQ is 8.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.6%TTM8.6%0.0%
TTM8.6%YOY48.2%-39.7%
TTM8.6%5Y22.6%-14.0%
5Y22.6%10Y22.3%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6%-15.8%+24.4%
TTM8.6%-15.7%+24.3%
YOY48.2%-13.9%+62.1%
5Y22.6%-18.3%+40.9%
10Y22.3%-19.2%+41.5%

1.2. Operating Efficiency of Sino Biopharmaceutical Ltd ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sino Biopharmaceutical Ltd ADR is operating .

  • Measures how much profit Sino Biopharmaceutical Ltd ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sino Biopharmaceutical Ltd ADR to the Biotechnology industry mean.
  • An Operating Margin of 23.2% means the company generated $0.23  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sino Biopharmaceutical Ltd ADR:

  • The MRQ is 23.2%. The company is operating efficient. +1
  • The TTM is 23.2%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ23.2%TTM23.2%0.0%
TTM23.2%YOY70.2%-47.0%
TTM23.2%5Y32.4%-9.1%
5Y32.4%10Y28.2%+4.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.2%-299.1%+322.3%
TTM23.2%-210.1%+233.3%
YOY70.2%-279.7%+349.9%
5Y32.4%-459.9%+492.3%
10Y28.2%-596.9%+625.1%
1.2.2. Operating Ratio

Measures how efficient Sino Biopharmaceutical Ltd ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are $0.79 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Sino Biopharmaceutical Ltd ADR:

  • The MRQ is 0.790. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.790. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.790TTM0.7900.000
TTM0.790YOY0.838-0.048
TTM0.7905Y0.806-0.016
5Y0.80610Y0.805+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7902.861-2.071
TTM0.7903.193-2.403
YOY0.8383.615-2.777
5Y0.8065.560-4.754
10Y0.8057.396-6.591

1.3. Liquidity of Sino Biopharmaceutical Ltd ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sino Biopharmaceutical Ltd ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.29 means the company has $1.29 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Sino Biopharmaceutical Ltd ADR:

  • The MRQ is 1.287. The company is just able to pay all its short-term debts.
  • The TTM is 1.287. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.287TTM1.2870.000
TTM1.287YOY1.532-0.245
TTM1.2875Y1.977-0.690
5Y1.97710Y2.074-0.096
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2873.986-2.699
TTM1.2874.440-3.153
YOY1.5325.552-4.020
5Y1.9776.158-4.181
10Y2.0746.492-4.418
1.3.2. Quick Ratio

Measures if Sino Biopharmaceutical Ltd ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sino Biopharmaceutical Ltd ADR to the Biotechnology industry mean.
  • A Quick Ratio of 1.44 means the company can pay off $1.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sino Biopharmaceutical Ltd ADR:

  • The MRQ is 1.436. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.436. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.436TTM1.4360.000
TTM1.436YOY1.794-0.358
TTM1.4365Y2.378-0.942
5Y2.37810Y2.479-0.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4363.638-2.202
TTM1.4364.168-2.732
YOY1.7945.515-3.721
5Y2.3786.012-3.634
10Y2.4796.209-3.730

1.4. Solvency of Sino Biopharmaceutical Ltd ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sino Biopharmaceutical Ltd ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sino Biopharmaceutical Ltd ADR to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.41 means that Sino Biopharmaceutical Ltd ADR assets are financed with 40.8% credit (debt) and the remaining percentage (100% - 40.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sino Biopharmaceutical Ltd ADR:

  • The MRQ is 0.408. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.408. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.408TTM0.4080.000
TTM0.408YOY0.377+0.031
TTM0.4085Y0.373+0.035
5Y0.37310Y0.370+0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4080.335+0.073
TTM0.4080.330+0.078
YOY0.3770.267+0.110
5Y0.3730.367+0.006
10Y0.3700.378-0.008
1.4.2. Debt to Equity Ratio

Measures if Sino Biopharmaceutical Ltd ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sino Biopharmaceutical Ltd ADR to the Biotechnology industry mean.
  • A Debt to Equity ratio of 87.8% means that company has $0.88 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sino Biopharmaceutical Ltd ADR:

  • The MRQ is 0.878. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.878. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.878TTM0.8780.000
TTM0.878YOY0.753+0.125
TTM0.8785Y0.822+0.056
5Y0.82210Y0.807+0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8780.376+0.502
TTM0.8780.398+0.480
YOY0.7530.334+0.419
5Y0.8220.429+0.393
10Y0.8070.476+0.331

2. Market Valuation of Sino Biopharmaceutical Ltd ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Sino Biopharmaceutical Ltd ADR generates.

  • Above 15 is considered overpriced but always compare Sino Biopharmaceutical Ltd ADR to the Biotechnology industry mean.
  • A PE ratio of 31.63 means the investor is paying $31.63 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sino Biopharmaceutical Ltd ADR:

  • The EOD is 22.149. Based on the earnings, the company is fair priced.
  • The MRQ is 31.632. Based on the earnings, the company is overpriced. -1
  • The TTM is 31.632. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD22.149MRQ31.632-9.483
MRQ31.632TTM31.6320.000
TTM31.632YOY6.680+24.953
TTM31.6325Y41.198-9.565
5Y41.19810Y37.241+3.957
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD22.149-2.643+24.792
MRQ31.632-2.418+34.050
TTM31.632-2.742+34.374
YOY6.680-4.123+10.803
5Y41.198-6.257+47.455
10Y37.241-6.478+43.719
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sino Biopharmaceutical Ltd ADR:

  • The EOD is 12.356. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 17.646. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 17.646. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.356MRQ17.646-5.290
MRQ17.646TTM17.6460.000
TTM17.646YOY28.102-10.456
TTM17.6465Y40.848-23.201
5Y40.84810Y36.323+4.525
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD12.356-3.244+15.600
MRQ17.646-2.939+20.585
TTM17.646-3.478+21.124
YOY28.102-5.592+33.694
5Y40.848-8.473+49.321
10Y36.323-8.881+45.204
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sino Biopharmaceutical Ltd ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.12 means the investor is paying $2.12 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Sino Biopharmaceutical Ltd ADR:

  • The EOD is 1.485. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.120. Based on the equity, the company is underpriced. +1
  • The TTM is 2.120. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.485MRQ2.120-0.636
MRQ2.120TTM2.1200.000
TTM2.120YOY2.586-0.466
TTM2.1205Y4.285-2.164
5Y4.28510Y5.007-0.723
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4852.124-0.639
MRQ2.1202.041+0.079
TTM2.1202.118+0.002
YOY2.5862.915-0.329
5Y4.2853.682+0.603
10Y5.0074.114+0.893
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sino Biopharmaceutical Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1070.1070%2.115-95%0.733-85%0.484-78%
Book Value Per Share--5.5235.5230%5.416+2%5.139+7%3.228+71%
Current Ratio--1.2871.2870%1.532-16%1.977-35%2.074-38%
Debt To Asset Ratio--0.4080.4080%0.377+8%0.373+9%0.370+10%
Debt To Equity Ratio--0.8780.8780%0.753+17%0.822+7%0.807+9%
Dividend Per Share--0.1850.1850%0.135+37%0.144+28%0.095+95%
Eps--0.3700.3700%2.097-82%0.923-60%0.581-36%
Free Cash Flow Per Share--0.6640.6640%0.498+33%0.540+23%0.378+76%
Free Cash Flow To Equity Per Share--0.2000.2000%0.035+464%0.439-54%0.307-35%
Gross Profit Margin---3.073-3.0730%0.280-1197%-1.473-52%-1.953-36%
Intrinsic Value_10Y_max--7.707--------
Intrinsic Value_10Y_min--4.450--------
Intrinsic Value_1Y_max--0.605--------
Intrinsic Value_1Y_min--0.399--------
Intrinsic Value_3Y_max--1.946--------
Intrinsic Value_3Y_min--1.247--------
Intrinsic Value_5Y_max--3.440--------
Intrinsic Value_5Y_min--2.140--------
Market Cap7708500134.400-44%11135522619.38911135522619.3890%13504817590.278-18%20340501363.228-45%15170435098.062-27%
Net Profit Margin--0.0880.0880%0.544-84%0.259-66%0.191-54%
Operating Margin--0.2320.2320%0.702-67%0.324-28%0.282-18%
Operating Ratio--0.7900.7900%0.838-6%0.806-2%0.805-2%
Pb Ratio1.485-43%2.1202.1200%2.586-18%4.285-51%5.007-58%
Pe Ratio22.149-43%31.63231.6320%6.680+374%41.198-23%37.241-15%
Price Per Share8.200-43%11.71111.7110%14.007-16%21.534-46%16.086-27%
Price To Free Cash Flow Ratio12.356-43%17.64617.6460%28.102-37%40.848-57%36.323-51%
Price To Total Gains Ratio28.139-43%40.18740.1870%6.226+546%25.042+60%46.256-13%
Quick Ratio--1.4361.4360%1.794-20%2.378-40%2.479-42%
Return On Assets--0.0400.0400%0.241-84%0.114-65%0.108-63%
Return On Equity--0.0860.0860%0.482-82%0.226-62%0.223-62%
Total Gains Per Share--0.2910.2910%2.250-87%0.877-67%0.578-50%
Usd Book Value--5251387043.2005251387043.2000%5221696783.200+1%4869637797.280+8%3054051044.421+72%
Usd Book Value Change Per Share--0.1070.1070%2.115-95%0.733-85%0.484-78%
Usd Book Value Per Share--5.5235.5230%5.416+2%5.139+7%3.228+71%
Usd Dividend Per Share--0.1850.1850%0.135+37%0.144+28%0.095+95%
Usd Eps--0.3700.3700%2.097-82%0.923-60%0.581-36%
Usd Free Cash Flow--631040751.200631040751.2000%480567704.000+31%511812611.200+23%357376237.786+77%
Usd Free Cash Flow Per Share--0.6640.6640%0.498+33%0.540+23%0.378+76%
Usd Free Cash Flow To Equity Per Share--0.2000.2000%0.035+464%0.439-54%0.307-35%
Usd Market Cap7708500134.400-44%11135522619.38911135522619.3890%13504817590.278-18%20340501363.228-45%15170435098.062-27%
Usd Price Per Share8.200-43%11.71111.7110%14.007-16%21.534-46%16.086-27%
Usd Profit--352030088.000352030088.0000%2021804220.800-83%876797465.120-60%540727538.513-35%
Usd Revenue--3983209020.8003983209020.8000%3717611670.400+7%3443713254.080+16%2535767761.864+57%
Usd Total Gains Per Share--0.2910.2910%2.250-87%0.877-67%0.578-50%
 EOD+4 -4MRQTTM+0 -0YOY+16 -205Y+15 -2110Y+14 -22

3.2. Fundamental Score

Let's check the fundamental score of Sino Biopharmaceutical Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1522.149
Price to Book Ratio (EOD)Between0-11.485
Net Profit Margin (MRQ)Greater than00.088
Operating Margin (MRQ)Greater than00.232
Quick Ratio (MRQ)Greater than11.436
Current Ratio (MRQ)Greater than11.287
Debt to Asset Ratio (MRQ)Less than10.408
Debt to Equity Ratio (MRQ)Less than10.878
Return on Equity (MRQ)Greater than0.150.086
Return on Assets (MRQ)Greater than0.050.040
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Sino Biopharmaceutical Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.881
Ma 20Greater thanMa 507.773
Ma 50Greater thanMa 1008.421
Ma 100Greater thanMa 2008.566
OpenGreater thanClose8.200
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets64,064,284
Total Liabilities26,120,736
Total Stockholder Equity29,747,035
 As reported
Total Liabilities 26,120,736
Total Stockholder Equity+ 29,747,035
Total Assets = 64,064,284

Assets

Total Assets64,064,284
Total Current Assets25,934,905
Long-term Assets38,129,379
Total Current Assets
Cash And Cash Equivalents 8,654,805
Short-term Investments 8,266,858
Net Receivables 3,752,154
Inventory 2,328,844
Total Current Assets  (as reported)25,934,905
Total Current Assets  (calculated)23,002,661
+/- 2,932,244
Long-term Assets
Property Plant Equipment 9,251,183
Goodwill 662,611
Intangible Assets 1,251,839
Long-term Assets Other 9,495,873
Long-term Assets  (as reported)38,129,379
Long-term Assets  (calculated)20,661,506
+/- 17,467,873

Liabilities & Shareholders' Equity

Total Current Liabilities20,150,677
Long-term Liabilities5,970,059
Total Stockholder Equity29,747,035
Total Current Liabilities
Short-term Debt 9,723,841
Short Long Term Debt 9,663,410
Accounts payable 1,637,351
Other Current Liabilities 8,789,485
Total Current Liabilities  (as reported)20,150,677
Total Current Liabilities  (calculated)29,814,087
+/- 9,663,410
Long-term Liabilities
Long term Debt 3,933,859
Capital Lease Obligations 384,694
Long-term Liabilities Other 131,076
Long-term Liabilities  (as reported)5,970,059
Long-term Liabilities  (calculated)4,449,629
+/- 1,520,430
Total Stockholder Equity
Common Stock414,899
Retained Earnings 23,069,898
Other Stockholders Equity 6,262,238
Total Stockholder Equity (as reported)29,747,035
Total Stockholder Equity (calculated)29,747,035
+/-0
Other
Capital Stock414,899
Cash and Short Term Investments 16,921,663
Common Stock Shares Outstanding 950,860
Liabilities and Stockholders Equity 64,064,284
Net Debt 5,327,158
Net Invested Capital 43,344,304
Net Working Capital 5,784,228
Property Plant and Equipment Gross 13,858,265
Short Long Term Debt Total 13,981,963



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
> Total Assets 
287,569
404,881
459,658
630,368
784,745
978,337
2,227,834
2,221,092
2,431,608
2,876,943
3,316,055
4,790,217
5,095,122
6,292,710
7,789,741
11,326,059
13,802,211
18,391,162
20,935,339
49,780,208
58,299,251
47,210,438
60,543,337
64,064,284
64,064,28460,543,33747,210,43858,299,25149,780,20820,935,33918,391,16213,802,21111,326,0597,789,7416,292,7105,095,1224,790,2173,316,0552,876,9432,431,6082,221,0922,227,834978,337784,745630,368459,658404,881287,569
   > Total Current Assets 
165,484
251,734
294,563
409,744
436,521
491,321
1,930,837
1,865,010
1,942,807
2,164,966
2,324,236
3,434,227
3,133,056
4,123,650
4,553,173
6,541,479
8,319,980
12,725,461
13,780,119
18,538,125
24,913,095
22,794,203
23,503,178
25,934,905
25,934,90523,503,17822,794,20324,913,09518,538,12513,780,11912,725,4618,319,9806,541,4794,553,1734,123,6503,133,0563,434,2272,324,2362,164,9661,942,8071,865,0101,930,837491,321436,521409,744294,563251,734165,484
       Cash And Cash Equivalents 
57,713
132,564
182,493
297,707
307,978
294,278
1,765,441
1,688,710
1,663,517
1,650,950
1,608,856
1,992,924
1,707,805
2,012,673
2,258,589
2,532,645
2,119,307
3,500,506
3,692,044
6,235,029
10,631,210
10,624,194
9,599,537
8,654,805
8,654,8059,599,53710,624,19410,631,2106,235,0293,692,0443,500,5062,119,3072,532,6452,258,5892,012,6731,707,8051,992,9241,608,8561,650,9501,663,5171,688,7101,765,441294,278307,978297,707182,493132,56457,713
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
47,454
418,633
106,131
402,639
179,420
1,463,961
2,562,956
5,069,559
6,212,252
6,787,642
8,474,344
5,807,629
6,194,514
8,266,858
8,266,8586,194,5145,807,6298,474,3446,787,6426,212,2525,069,5592,562,9561,463,961179,420402,639106,131418,63347,4540000000000
       Net Receivables 
0
0
72,195
63,998
0
0
106,189
0
205,632
0
0
0
0
0
1,719,032
2,124,054
2,083,080
3,091,931
2,744,791
3,865,169
3,342,972
4,075,751
5,537,259
3,752,154
3,752,1545,537,2594,075,7513,342,9723,865,1692,744,7913,091,9312,083,0802,124,0541,719,03200000205,6320106,1890063,99872,19500
       Inventory 
30,061
36,753
39,858
48,023
61,516
62,871
46,154
40,987
65,693
163,108
186,099
314,606
365,598
475,786
629,301
720,976
795,635
894,640
918,819
1,209,160
1,658,597
1,880,051
1,937,741
2,328,844
2,328,8441,937,7411,880,0511,658,5971,209,160918,819894,640795,635720,976629,301475,786365,598314,606186,099163,10865,69340,98746,15462,87161,51648,02339,85836,75330,061
   > Long-term Assets 
122,085
153,147
165,095
220,623
348,224
487,016
296,997
356,082
488,801
711,977
991,819
1,355,990
1,962,066
2,169,060
3,236,568
4,784,580
5,482,231
5,665,701
7,155,220
31,242,083
33,386,156
24,416,235
37,040,159
38,129,379
38,129,37937,040,15924,416,23533,386,15631,242,0837,155,2205,665,7015,482,2314,784,5803,236,5682,169,0601,962,0661,355,990991,819711,977488,801356,082296,997487,016348,224220,623165,095153,147122,085
       Property Plant Equipment 
85,604
117,453
129,556
183,907
211,060
295,487
206,794
238,598
317,949
514,304
788,257
1,059,315
1,366,004
1,672,335
1,797,298
2,142,661
2,503,825
3,150,776
4,272,615
7,026,468
6,976,357
7,158,219
8,516,062
9,251,183
9,251,1838,516,0627,158,2196,976,3577,026,4684,272,6153,150,7762,503,8252,142,6611,797,2981,672,3351,366,0041,059,315788,257514,304317,949238,598206,794295,487211,060183,907129,556117,45385,604
       Goodwill 
4,735
4,083
3,311
2,534
3,132
2,143
43,665
42,145
41,521
41,986
41,983
57,362
63,654
63,349
45,386
88,640
92,705
98,956
88,926
13,896,976
13,896,976
88,926
647,930
662,611
662,611647,93088,92613,896,97613,896,97688,92698,95692,70588,64045,38663,34963,65457,36241,98341,98641,52142,14543,6652,1433,1322,5343,3114,0834,735
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,261,869
1,786,984
1,851,663
1,412,087
1,778,714
1,069,609
0
0
0
0
00001,069,6091,778,7141,412,0871,851,6631,786,9841,261,86900000000000000
       Intangible Assets 
0
0
582
2,535
4,035
9,090
3,958
19,395
27,920
38,584
48,455
55,528
61,287
68,819
68,575
129,728
166,561
182,473
219,249
8,349,174
8,934,491
2,158,695
1,064,016
1,251,839
1,251,8391,064,0162,158,6958,934,4918,349,174219,249182,473166,561129,72868,57568,81961,28755,52848,45538,58427,92019,3953,9589,0904,0352,53558200
       Long-term Assets Other 
31,745
31,611
31,646
31,646
129,997
171,811
38,783
51,689
27,431
114,105
231,687
1,077,434
946,649
1,330,722
846,348
4,744,528
7,103,085
11,062,033
13,250,788
7,216,939
9,452,205
9,447,840
7,502,315
9,495,873
9,495,8737,502,3159,447,8409,452,2057,216,93913,250,78811,062,0337,103,0854,744,528846,3481,330,722946,6491,077,434231,687114,10527,43151,68938,783171,811129,99731,64631,64631,61131,745
> Total Liabilities 
141,186
152,961
97,423
181,955
255,541
263,922
171,732
184,107
351,637
541,903
650,104
1,124,330
1,229,476
1,634,912
2,144,105
4,274,593
5,057,416
7,701,900
8,324,290
12,230,684
18,014,683
24,790,880
22,814,314
26,120,736
26,120,73622,814,31424,790,88018,014,68312,230,6848,324,2907,701,9005,057,4164,274,5932,144,1051,634,9121,229,4761,124,330650,104541,903351,637184,107171,732263,922255,541181,95597,423152,961141,186
   > Total Current Liabilities 
141,186
152,961
97,423
132,288
172,376
215,525
169,229
171,369
303,147
510,357
604,872
933,664
1,109,200
1,514,986
2,015,928
3,087,629
4,625,729
5,653,228
5,688,451
9,668,621
8,123,025
10,943,539
15,345,019
20,150,677
20,150,67715,345,01910,943,5398,123,0259,668,6215,688,4515,653,2284,625,7293,087,6292,015,9281,514,9861,109,200933,664604,872510,357303,147171,369169,229215,525172,376132,28897,423152,961141,186
       Short-term Debt 
55,924
25,538
0
0
0
0
0
0
34,643
90,007
1,000
24,063
40,944
17,027
57,944
347,993
1,189,071
1,368,719
741,307
2,905,575
689,828
1,581,524
6,585,038
9,723,841
9,723,8416,585,0381,581,524689,8282,905,575741,3071,368,7191,189,071347,99357,94417,02740,94424,0631,00090,00734,64300000025,53855,924
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
74,153
12,491
15,870
1,368,719
741,307
2,905,575
666,749
1,552,825
6,520,565
9,663,410
9,663,4106,520,5651,552,825666,7492,905,575741,3071,368,71915,87012,49174,15300000000000000
       Accounts payable 
14,958
13,718
17,389
25,934
22,843
18,151
21,401
23,932
33,881
65,521
108,376
135,943
178,605
242,208
371,171
619,914
642,766
826,279
928,607
1,832,166
1,809,445
1,947,802
1,693,152
1,637,351
1,637,3511,693,1521,947,8021,809,4451,832,166928,607826,279642,766619,914371,171242,208178,605135,943108,37665,52133,88123,93221,40118,15122,84325,93417,38913,71814,958
       Other Current Liabilities 
70,304
113,706
80,034
106,354
149,533
197,373
147,829
147,436
234,623
354,829
495,496
773,658
889,652
1,255,752
1,586,814
2,119,722
2,793,892
3,458,230
4,018,537
4,930,880
5,623,752
7,414,213
7,066,829
8,789,485
8,789,4857,066,8297,414,2135,623,7524,930,8804,018,5373,458,2302,793,8922,119,7221,586,8141,255,752889,652773,658495,496354,829234,623147,436147,829197,373149,533106,35480,034113,70670,304
   > Long-term Liabilities 
0
0
0
49,667
83,166
48,398
2,502
12,738
48,490
31,546
45,231
190,667
120,275
119,925
128,177
1,186,965
431,687
2,048,671
2,635,839
2,562,063
9,891,658
13,847,341
7,469,295
5,970,059
5,970,0597,469,29513,847,3419,891,6582,562,0632,635,8392,048,671431,6871,186,965128,177119,925120,275190,66745,23131,54648,49012,7382,50248,39883,16649,667000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
164,034
195,776
209,459
370,833
425,942
2,054,997
903,913
1,219,041
1,936,820
0
01,936,8201,219,041903,9132,054,997425,942370,833209,459195,776164,03400000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
64,499
83,920
117,056
118,424
164,140
504,979
503,150
699,363
772,459
0
0772,459699,363503,150504,979164,140118,424117,05683,92064,49900000000000000
> Total Stockholder Equity
110,721
211,499
259,517
310,743
362,502
487,523
1,929,112
1,913,716
1,891,624
1,962,581
2,178,538
3,108,648
3,104,587
3,689,376
4,287,592
5,286,136
6,494,624
7,955,412
9,208,794
29,212,838
31,111,658
16,747,160
30,291,116
29,747,035
29,747,03530,291,11616,747,16031,111,65829,212,8389,208,7947,955,4126,494,6245,286,1364,287,5923,689,3763,104,5873,108,6482,178,5381,962,5811,891,6241,913,7161,929,112487,523362,502310,743259,517211,499110,721
   Common Stock
0
0
0
0
0
0
0
56,752
53,022
49,836
99,665
105,604
99,981
99,470
96,532
98,784
155,171
165,923
170,033
278,846
278,451
415,895
415,440
414,899
414,899415,440415,895278,451278,846170,033165,923155,17198,78496,53299,47099,981105,60499,66549,83653,02256,7520000000
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
201,605
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000201,60500000000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
227,680
279,032
0
0
0
475,108
283,464
540,051
1,994,650
1,518,079
1,578,086
1,802,309
1,887,085
2,077,977
2,225,003
2,451,864
9,038,761
28,933,992
30,833,207
16,331,265
6,804,276
6,262,238
6,262,2386,804,27616,331,26530,833,20728,933,9929,038,7612,451,8642,225,0032,077,9771,887,0851,802,3091,578,0861,518,0791,994,650540,051283,464475,108000279,032227,68000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue28,780,412
Cost of Revenue-5,795,510
Gross Profit22,984,90222,984,902
 
Operating Income (+$)
Gross Profit22,984,902
Operating Expense-16,948,603
Operating Income6,690,3076,036,299
 
Operating Expense (+$)
Research Development-
Selling General Administrative2,204,697
Selling And Marketing Expenses10,359,310
Operating Expense16,948,60312,564,007
 
Net Interest Income (+$)
Interest Income201,441
Interest Expense-439,058
Other Finance Cost-0
Net Interest Income-237,617
 
Pretax Income (+$)
Operating Income6,690,307
Net Interest Income-237,617
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,778,6047,602,010
EBIT - interestExpense = 6,251,249
3,319,556
2,982,628
Interest Expense439,058
Earnings Before Interest and Taxes (EBIT)6,690,3076,217,662
Earnings Before Interest and Taxes (EBITDA)7,737,291
 
After tax Income (+$)
Income Before Tax5,778,604
Tax Provision-775,986
Net Income From Continuing Ops5,002,6185,002,618
Net Income2,543,570
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses22,744,113
Total Other Income/Expenses Net-911,703237,617
 

Technical Analysis of Sino Biopharmaceutical Ltd ADR
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sino Biopharmaceutical Ltd ADR. The general trend of Sino Biopharmaceutical Ltd ADR is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sino Biopharmaceutical Ltd ADR's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sino Biopharmaceutical Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.95 < 8.95 < 8.95.

The bearish price targets are: 7.96 > 7.96 > 7.96.

Tweet this
Sino Biopharmaceutical Ltd ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sino Biopharmaceutical Ltd ADR. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sino Biopharmaceutical Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sino Biopharmaceutical Ltd ADR. The current macd is -0.04404871.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sino Biopharmaceutical Ltd ADR price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sino Biopharmaceutical Ltd ADR. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sino Biopharmaceutical Ltd ADR price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sino Biopharmaceutical Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartSino Biopharmaceutical Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sino Biopharmaceutical Ltd ADR. The current adx is 45.79.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sino Biopharmaceutical Ltd ADR shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Sino Biopharmaceutical Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sino Biopharmaceutical Ltd ADR. The current sar is 8.52451027.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sino Biopharmaceutical Ltd ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sino Biopharmaceutical Ltd ADR. The current rsi is 59.88. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Sino Biopharmaceutical Ltd ADR Daily Relative Strength Index (RSI) ChartSino Biopharmaceutical Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sino Biopharmaceutical Ltd ADR. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sino Biopharmaceutical Ltd ADR price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Sino Biopharmaceutical Ltd ADR Daily Stochastic Oscillator ChartSino Biopharmaceutical Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sino Biopharmaceutical Ltd ADR. The current cci is 92.68.

Sino Biopharmaceutical Ltd ADR Daily Commodity Channel Index (CCI) ChartSino Biopharmaceutical Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sino Biopharmaceutical Ltd ADR. The current cmo is 44.78.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sino Biopharmaceutical Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartSino Biopharmaceutical Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sino Biopharmaceutical Ltd ADR. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sino Biopharmaceutical Ltd ADR Daily Williams %R ChartSino Biopharmaceutical Ltd ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sino Biopharmaceutical Ltd ADR.

Sino Biopharmaceutical Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sino Biopharmaceutical Ltd ADR. The current atr is 0.08815532.

Sino Biopharmaceutical Ltd ADR Daily Average True Range (ATR) ChartSino Biopharmaceutical Ltd ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sino Biopharmaceutical Ltd ADR. The current obv is -72,767.

Sino Biopharmaceutical Ltd ADR Daily On-Balance Volume (OBV) ChartSino Biopharmaceutical Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sino Biopharmaceutical Ltd ADR. The current mfi is 7.4447717.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Sino Biopharmaceutical Ltd ADR Daily Money Flow Index (MFI) ChartSino Biopharmaceutical Ltd ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sino Biopharmaceutical Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Sino Biopharmaceutical Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sino Biopharmaceutical Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.881
Ma 20Greater thanMa 507.773
Ma 50Greater thanMa 1008.421
Ma 100Greater thanMa 2008.566
OpenGreater thanClose8.200
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sino Biopharmaceutical Ltd ADR with someone you think should read this too:
  • Are you bullish or bearish on Sino Biopharmaceutical Ltd ADR? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sino Biopharmaceutical Ltd ADR? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sino Biopharmaceutical Ltd ADR

I send you an email if I find something interesting about Sino Biopharmaceutical Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Sino Biopharmaceutical Ltd ADR.

Receive notifications about Sino Biopharmaceutical Ltd ADR in your mailbox!